FindTrial
Sign In

Painless alternative for oral tablets and injections- the SKIN PATCHES

COMPARATIVE EVALUATION OF SUSTAINED TRANSDERMAL DELIVERY AND ORAL ADMINISTRATION OF ANALGESIC IN POST-OPERATIVE PAIN MANAGEMENT FOLLOWING MINOR ORAL SURGERY. - TransDAn

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031314
Enrollment
160
Registered
2021-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K039- Disease of hard tissues of teeth,unspecified

Interventions

Intervention1: transdermal diclofenac patch: transdermal diclofenac patch for pain control- 100mg every 24hours for 3days Control Intervention1: diclofenac sodium oral tablets: diclofenac tablets 50mg

Sponsors

SIBAR INSTITUTE OF DENTAL SCIENCES
Lead Sponsor
no secondary sponsor
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: all healthy individuals between 18-60 years of age, patients without allergy to NSAIDs

Exclusion criteria

Exclusion criteria: patients with history of any systemic disease, patients allergic to NSAIDs, patients who are on analgesics or sedatives for any other medical issues, smokers and alcoholics, pregnancy and lactating women, habitual substance abuse

Design outcomes

Primary

MeasureTime frame
Transdermal patch is anticipated to be effective for post-operative pain management, with enhanced compliance and overall experience of the patient.Timepoint: Immediate post-operative period, post-operative day 1, day 2 and day 3.—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactAKULA SWETHA

SIBAR Institute of Dental Sciences

drphanisurgery@sids.ac.in8096339404

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026